Prevalence of colibactin positive E. colin in colorectal cancer patients
Project/Area Number |
26460962
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | The University of Tokyo |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
平田 喜裕 東京大学, 医学部附属病院, 助教 (10529192)
|
Research Collaborator |
OTA YUMIKO 東京大学, 医学部附属病院, 特任臨床医
SHIMPOH TAKAYUKI 東京大学, 医学部附属病院, 特任臨床医
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 大腸癌 / 大腸菌 / スクリーニング / 腸内細菌 |
Outline of Final Research Achievements |
Colorectal cancer (CRC) development is considered to be affected by luminal microbiota, and colibactin positive Escherichia coli (E. coli) is shown to be one of those microorganism from foreign studies. We examined the prevalence of colibactin positive bacteria in colonic lavage of CRC patients in Japan. We established DNA preparation method from colonic lavage and qualitative, quantitative detection method of colibactin (clbB) gene. Prevalence of colibactin positive bacteria was 43% in CRC cases, and 51% in control cases, providing no significant differences. In subgroup analysis of CRC cases, colibactin negative bacteria was associated with wild type k-ras gene, but not other clinicopathological factors. These results suggest that CRC in Japanese, especially k-ras wild CRC, may have different pathogenesis from CRC in other countries. Factors other than colibactin positive bacteria may be associated with the development of CRC in Japan.
|
Report
(4 results)
Research Products
(1 results)
-
[Journal Article] Characterization of a New Small Bowel Adenocarcinoma Cell Line and Screening of Anti-Cancer Drug against Small Bowel Adenocarcinoma2015
Author(s)
Hirobumi Suzuki, Yoshihiro Hirata, Nobumi Suzuki, Sozaburo Ihara, Kosuke Sakitani, Yuka Kobayashi, Hiroto Kinoshita,Yoku Hayakawa, Atsuo Yamada, Hirotsugu Watabe, Keisuke Tateishi, Tsuneo Ikenoue, Yutaka Yamaji, and Kazuhiko Koike
-
Journal Title
American Journal of Pathology
Volume: 185
Issue: 2
Pages: 550-562
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant